- Home
- XGN vs PFD Comparison
XGN vs PFD Comparison
Compare XGN & PFD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | XGN | PFD |
|---|---|---|
| Founded | 2002 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 138.0M | 152.5M |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | XGN | PFD |
|---|---|---|
| Price | $5.00 | $11.85 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $13.67 | N/A |
| AVG Volume (30 Days) | ★ 601.6K | 33.2K |
| Earning Date | 03-10-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 6.30% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $63,599,000.00 | N/A |
| Revenue This Year | $21.40 | N/A |
| Revenue Next Year | $14.82 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 14.08 | N/A |
| 52 Week Low | $2.67 | $8.53 |
| 52 Week High | $12.23 | $11.18 |
Technical Indicators
Market Signals| Indicator | XGN | PFD |
|---|---|---|
| Relative Strength Index (RSI) | 29.79 | 49.00 |
| Support Level | $4.41 | $11.67 |
| Resistance Level | $6.75 | $12.07 |
| Average True Range (ATR) | 0.46 | 0.14 |
| MACD | -0.03 | -0.01 |
| Stochastic Oscillator | 25.21 | 40.42 |
Price Performance
Historical ComparisonAbout XGN Exagen Inc.
Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists.
About PFD Flaherty & Crumrine Preferred and Income Fund Incorporated
Flaherty & Crumrine Prefd Inc Fund Inc is a United States-based diversified, closed-end management investment company. Its investment objective is to provide its common shareholders with high current income consistent with the preservation of capital. The fund invests in a diversified portfolio of preferred securities, which includes traditional preferred stocks eligible for the inter-corporate dividends received a deduction and fully taxable preferred securities.